nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—hypertension—focal segmental glomerulosclerosis	0.837	1	CtDrD
Metoprolol—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0424	0.389	CbGbCtD
Metoprolol—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0342	0.314	CbGbCtD
Metoprolol—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0322	0.296	CbGbCtD
Metoprolol—SLC22A2—nephron—focal segmental glomerulosclerosis	0.00645	0.56	CbGeAlD
Metoprolol—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.0435	CcSEcCtD
Metoprolol—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.04	CcSEcCtD
Metoprolol—Thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.0394	CcSEcCtD
Metoprolol—SLC22A2—nephron tubule—focal segmental glomerulosclerosis	0.00139	0.121	CbGeAlD
Metoprolol—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0314	CcSEcCtD
Metoprolol—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0294	CcSEcCtD
Metoprolol—SLC22A2—kidney—focal segmental glomerulosclerosis	0.00122	0.106	CbGeAlD
Metoprolol—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0282	CcSEcCtD
Metoprolol—SLC22A2—cortex of kidney—focal segmental glomerulosclerosis	0.00119	0.104	CbGeAlD
Metoprolol—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.000906	0.0213	CcSEcCtD
Metoprolol—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000893	0.021	CcSEcCtD
Metoprolol—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.000824	0.0194	CcSEcCtD
Metoprolol—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.0178	CcSEcCtD
Metoprolol—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.000717	0.0169	CcSEcCtD
Metoprolol—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.000681	0.016	CcSEcCtD
Metoprolol—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000655	0.0154	CcSEcCtD
Metoprolol—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000652	0.0154	CcSEcCtD
Metoprolol—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.015	CcSEcCtD
Metoprolol—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.015	CcSEcCtD
Metoprolol—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.0145	CcSEcCtD
Metoprolol—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.000609	0.0143	CcSEcCtD
Metoprolol—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.000604	0.0142	CcSEcCtD
Metoprolol—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.000601	0.0142	CcSEcCtD
Metoprolol—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000586	0.0138	CcSEcCtD
Metoprolol—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000584	0.0137	CcSEcCtD
Metoprolol—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000584	0.0137	CcSEcCtD
Metoprolol—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.000565	0.0133	CcSEcCtD
Metoprolol—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000561	0.0132	CcSEcCtD
Metoprolol—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00054	0.0127	CcSEcCtD
Metoprolol—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00052	0.0123	CcSEcCtD
Metoprolol—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000515	0.0121	CcSEcCtD
Metoprolol—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000513	0.0121	CcSEcCtD
Metoprolol—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000484	0.0114	CcSEcCtD
Metoprolol—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00048	0.0113	CcSEcCtD
Metoprolol—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000448	0.0106	CcSEcCtD
Metoprolol—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000441	0.0104	CcSEcCtD
Metoprolol—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000438	0.0103	CcSEcCtD
Metoprolol—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000428	0.0101	CcSEcCtD
Metoprolol—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000427	0.0101	CcSEcCtD
Metoprolol—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000415	0.00978	CcSEcCtD
Metoprolol—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000395	0.00931	CcSEcCtD
Metoprolol—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000394	0.00928	CcSEcCtD
Metoprolol—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000387	0.0337	CbGeAlD
Metoprolol—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000387	0.00912	CcSEcCtD
Metoprolol—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00038	0.00895	CcSEcCtD
Metoprolol—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000367	0.00865	CcSEcCtD
Metoprolol—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000358	0.00842	CcSEcCtD
Metoprolol—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000355	0.00837	CcSEcCtD
Metoprolol—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000352	0.00829	CcSEcCtD
Metoprolol—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000348	0.0082	CcSEcCtD
Metoprolol—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000345	0.00813	CcSEcCtD
Metoprolol—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000338	0.00796	CcSEcCtD
Metoprolol—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000337	0.00793	CcSEcCtD
Metoprolol—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000336	0.00791	CcSEcCtD
Metoprolol—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000333	0.00785	CcSEcCtD
Metoprolol—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00033	0.00777	CcSEcCtD
Metoprolol—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000323	0.00762	CcSEcCtD
Metoprolol—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000317	0.0276	CbGeAlD
Metoprolol—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000308	0.00726	CcSEcCtD
Metoprolol—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000307	0.00723	CcSEcCtD
Metoprolol—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000296	0.00698	CcSEcCtD
Metoprolol—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000292	0.00688	CcSEcCtD
Metoprolol—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000292	0.00688	CcSEcCtD
Metoprolol—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000291	0.00686	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.00683	CcSEcCtD
Metoprolol—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.00673	CcSEcCtD
Metoprolol—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000282	0.00665	CcSEcCtD
Metoprolol—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00028	0.00659	CcSEcCtD
Metoprolol—ABCB1—kidney—focal segmental glomerulosclerosis	0.000279	0.0242	CbGeAlD
Metoprolol—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00647	CcSEcCtD
Metoprolol—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000274	0.00646	CcSEcCtD
Metoprolol—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000272	0.00641	CcSEcCtD
Metoprolol—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000271	0.0236	CbGeAlD
Metoprolol—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000271	0.00638	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000255	0.00601	CcSEcCtD
Metoprolol—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000253	0.00596	CcSEcCtD
Metoprolol—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000251	0.00592	CcSEcCtD
Metoprolol—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00025	0.00588	CcSEcCtD
Metoprolol—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000249	0.00586	CcSEcCtD
Metoprolol—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000246	0.00581	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000242	0.00569	CcSEcCtD
Metoprolol—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000241	0.00569	CcSEcCtD
Metoprolol—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000239	0.00564	CcSEcCtD
Metoprolol—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000239	0.00564	CcSEcCtD
Metoprolol—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000231	0.00543	CcSEcCtD
Metoprolol—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.00539	CcSEcCtD
Metoprolol—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000222	0.00524	CcSEcCtD
Metoprolol—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000221	0.00521	CcSEcCtD
Metoprolol—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000221	0.00521	CcSEcCtD
Metoprolol—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000206	0.00486	CcSEcCtD
Metoprolol—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000201	0.00473	CcSEcCtD
Metoprolol—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000198	0.00467	CcSEcCtD
Metoprolol—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.00451	CcSEcCtD
Metoprolol—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000185	0.00436	CcSEcCtD
Metoprolol—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000178	0.00419	CcSEcCtD
Metoprolol—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000177	0.00416	CcSEcCtD
Metoprolol—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00415	CcSEcCtD
Metoprolol—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000175	0.00413	CcSEcCtD
Metoprolol—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000166	0.00392	CcSEcCtD
